Back to top

moving-average-crossover: Archive

Zacks Equity Research

Amprius (AMPX) Surges 10.3%: Is This an Indication of Further Gains?

Amprius (AMPX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

AMPXNegative Net Change NABLPositive Net Change

Zacks Equity Research

Select Water Solutions, Inc. (WTTR) Surges 14.0%: Is This an Indication of Further Gains?

Select Water Solutions, Inc. (WTTR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

WTTRNegative Net Change VLTOPositive Net Change

Zacks Equity Research

Tecogen (TGEN) Soars 26.7%: Is Further Upside Left in the Stock?

Tecogen (TGEN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

TGENNegative Net Change TTNegative Net Change

Zacks Equity Research

New Oriental (EDU) Moves 10.5% Higher: Will This Strength Last?

New Oriental (EDU) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

EDUPositive Net Change STRANegative Net Change

Zacks Equity Research

Westinghouse Air Brake Technologies (WAB) Just Overtook the 20-Day Moving Average

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?

WABNegative Net Change

Zacks Equity Research

IBM (IBM) Recently Broke Out Above the 20-Day Moving Average

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

IBMNegative Net Change

Zacks Equity Research

KLA (KLAC) Recently Broke Out Above the 20-Day Moving Average

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

KLACNegative Net Change

Zacks Equity Research

Veracyte (VCYT) Crossed Above the 20-Day Moving Average: What That Means for Investors

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?

VCYTNegative Net Change

Zacks Equity Research

Xeris Biopharma (XERS) Surges 14.2%: Is This an Indication of Further Gains?

Xeris Biopharma (XERS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

XERSNegative Net Change ZTSPositive Net Change

Zacks Equity Research

Zevra Therapeutics (ZVRA) Surges 12.3%: Is This an Indication of Further Gains?

Zevra Therapeutics (ZVRA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

ZVRANegative Net Change OABINegative Net Change